Influenza vaccines: Time for a rethink

JAMA Internal Medicine

Volumn 173, Issue 11, 2013, Pages 1014-1016

  Doshi, Peter ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADVERSE OUTCOME; AGED; ARTICLE; DRUG MANUFACTURE; FEBRILE CONVULSION; HEALTH CARE POLICY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LONG TERM CARE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84878790720     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.490     Document Type: Article

References (27)

1. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2010;(7):CD001269.
2. Jefferson T. Mistaken identity: seasonal influenza versus influenza-like illness [published online October 5, 2009]. BMJ Clinical Evidence. http://www.clinicalevidence.com/x/mce/file/05-10-09.pdf. Accessed February 6, 2013.
3. US Centers for Disease Control and Prevention. Flu vaccine facts&myths. 2003. http: //www.ama-assn.org/resources/doc/infectious- disease/flu-kit -myth.pdf. Accessed November 3, 2013.
4. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010;(2):CD004876.
5. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661-1665. (Pubitemid 24359136)
6. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123(7):518-527.
7. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med . 2007;357(14):1373-1381. (Pubitemid 47535592)
8. Fiore AE, Uyeki TM, Broder K, et al Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1-62.
9. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165(3):265-272. (Pubitemid 40216277)
10. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-344.
11. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35(2):345-352.
12. Eurich DT, Marrie TJ, Johnstone J, Majumdar SR. Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding? Am J Respir Crit Care Med. 2008;178(5):527-533.
13. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333(7581):1241.
14. Lemaitre M, Meret T, Rothan-Tondeur M, et al. Effect of influenza vaccination of nursing home staff on mortality of residents: a clusterrandomized trial. J Am Geriatr Soc. 2009;57(9):1580-1586.
15. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev. 2010;(2):CD005187.
16. Osterholm MT, Kelley NS, Manske JM, Ballering KS, Leighton TR, Moore KA. The compelling need for game-changing influenza vaccines: an analysis of the influenza vaccine enterprise and recommendations for the future. Center for Infectious Disease Research & Policy; October 2012:160. http://www.cidrap. umn.edu/cidrap/files/80/ccivi%20report.pdf. Accessed November 3, 2013.
17. Simonsen L, Viboud C, Taylor R. Influenza vaccination in elderly people. Lancet . 2005;366(9503):2086.
18. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012;8:CD004879.
19. Stokes B. Ministerial review into the public health response into the adverse events to the seasonal influenza vaccine. Department of Health, Government of Western Australia; July 2010. http://www.health.wa.gov.au/ publications/documents/Stokes-Report.pdf. Accessed August 18, 2013.
20. Australian Government Department of Health and Ageing, Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination.2010.http://www.tga.gov.au/ safety/alerts-medicine-seasonal-flu-100702.htm.Accessed November 3, 2013.
21. European Medicines Agency. European Medicines Agency recommends restricting use of Pandemrix. October 19, 2012. http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news-and-events/news/2012/10/news-detail-001636. jsp&mid=WC0b01ac058004d5c1. Accessed November 3, 2013.
22. European Medicines Agency. European Medicines Agency reviews hypothesis on Pandemrix and development of narcolepsy. October 19, 2012. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2012/10/ news-detail-001636.jsp&mid=WC0b01ac058004d5c1.Accessed November 3, 2012.
23. Skowronski DM, De Serres G, Crowcroft NS, et al Canadian SAVOIR Team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med. 2010;7(4):e1000258.
24. Bodewes R, Kreijtz JHCM, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis. 2009;9(12):784-788.
25. Kelly H, Carcione D, Dowse GK, Effler P. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010. Euro Surveill. 2010;15(37):pii=19661.
26. Bodewes R, Fraaij PLA, Geelhoed-Mieras MM, et al. Annual vaccination against influenza virus hampers development of virus-specific CD8A+T cell immunity in children. J Virol. 2011;85(22):11995-12000.
27. Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2010;(1):CD006207.